Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Novel Inhibitors against Neuroblastoma

01.07.2013
Neuroblastoma is a malignant cancer, which occurs chiefly in infants. University of Würzburg scientists now present novel inhibitors able to suppress the growth of these tumors in the journal "Cancer Cell".
Neuroblastoma is one of the most common cancers in children up to one year of age. Neuroblastomas develop when certain nerve cells degenerate and form sizable lumps – in most cases in the abdomen of the child. About 130 cases of the disease are diagnosed each year in Germany.

In contrast to many other types of cancer, neuroblastomas sometimes heal spontaneously. In most patients, this type of cancer can be easily treated with conventional drugs. However, the chances of recovery and survival are slim in 20 percent of the cases. The reason: The tumors form metastases that don't much respond to conventional drugs.

Why the tumor becomes aggressive

"The most important factor for a poor prognosis is an amplification of the MYCN gene," says Professor Martin Eilers at the Biocenter of the University of Würzburg. This leads to an increased production of the MYCN protein, which is assumed to be responsible for the aggressive growth and the resistance to therapy of the tumors.

The MYCN protein stimulates cell growth. In normal cells, it can only be active for a short while, because it is quickly degraded. The situation is different in neuroblastomas: There, the protein is protected from fast degradation, because it is bound to a partner protein (Aurora-A). This was shown by Martin Eilers' study group in 2009.

How the novel inhibitors work

Together with an international team, the Würzburg study group has now made further progress in this research: They identified novel inhibitors that are able to disrupt the complex of Aurora-A and MYCN. If aggressive neuroblastomas are treated with these inhibitors, they cease to grow. At least, this is the result of tests in a mouse model.
"This might show the way to the development of new and better drugs against this aggressive tumor," says Eilers. According to the professor, other long-known inhibitors of the Aurora-A protein are already being tested in the first clinical trials in the USA.

The inhibitors of Aurora-A are promising for the treatment of other types of cancer as well: The fatal complex of Aurora-A and the MYCN protein is also present in particularly aggressive prostate carcinomas.

"Small Molecule Inhibitors of Aurora-A Induce Proteasomal Degradation of N-Myc in Childhood Neuroblastoma", Markus Brockmann, Evon Poon, Teeara Berry, Anne Carstensen, Hedwig E. Deubzer, Lukas Rycak, Yann Jamin, Khin Thway, Simon P. Robinson, Frederik Roels, Olaf Witt, Matthias Fischer, Louis Chesler, Martin Eilers, Cancer Cell, 20 June 2013, DOI 10.1016/j.ccr.2013.05.005

Contact person

Prof. Dr. Martin Eilers, Biocenter at the University of Würzburg, T +49 (0)931 888-4442, martin.eilers@biozentrum.uni-wuerzburg.de

Gunnar Bartsch | Uni Würzburg
Further information:
http://www.uni-wuerzburg.de

Further reports about: Biocenter Cancer MYCN Small Molecule aurora-A nerve cell neuroblastoma types of cancer

More articles from Life Sciences:

nachricht New technique unveils 'matrix' inside tissues and tumors
29.06.2017 | University of Copenhagen The Faculty of Health and Medical Sciences

nachricht Designed proteins to treat muscular dystrophy
29.06.2017 | Universität Basel

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Making Waves

Computer scientists use wave packet theory to develop realistic, detailed water wave simulations in real time. Their results will be presented at this year’s SIGGRAPH conference.

Think about the last time you were at a lake, river, or the ocean. Remember the ripples of the water, the waves crashing against the rocks, the wake following...

Im Focus: Can we see monkeys from space? Emerging technologies to map biodiversity

An international team of scientists has proposed a new multi-disciplinary approach in which an array of new technologies will allow us to map biodiversity and the risks that wildlife is facing at the scale of whole landscapes. The findings are published in Nature Ecology and Evolution. This international research is led by the Kunming Institute of Zoology from China, University of East Anglia, University of Leicester and the Leibniz Institute for Zoo and Wildlife Research.

Using a combination of satellite and ground data, the team proposes that it is now possible to map biodiversity with an accuracy that has not been previously...

Im Focus: Climate satellite: Tracking methane with robust laser technology

Heatwaves in the Arctic, longer periods of vegetation in Europe, severe floods in West Africa – starting in 2021, scientists want to explore the emissions of the greenhouse gas methane with the German-French satellite MERLIN. This is made possible by a new robust laser system of the Fraunhofer Institute for Laser Technology ILT in Aachen, which achieves unprecedented measurement accuracy.

Methane is primarily the result of the decomposition of organic matter. The gas has a 25 times greater warming potential than carbon dioxide, but is not as...

Im Focus: How protons move through a fuel cell

Hydrogen is regarded as the energy source of the future: It is produced with solar power and can be used to generate heat and electricity in fuel cells. Empa researchers have now succeeded in decoding the movement of hydrogen ions in crystals – a key step towards more efficient energy conversion in the hydrogen industry of tomorrow.

As charge carriers, electrons and ions play the leading role in electrochemical energy storage devices and converters such as batteries and fuel cells. Proton...

Im Focus: A unique data centre for cosmological simulations

Scientists from the Excellence Cluster Universe at the Ludwig-Maximilians-Universität Munich have establised "Cosmowebportal", a unique data centre for cosmological simulations located at the Leibniz Supercomputing Centre (LRZ) of the Bavarian Academy of Sciences. The complete results of a series of large hydrodynamical cosmological simulations are available, with data volumes typically exceeding several hundred terabytes. Scientists worldwide can interactively explore these complex simulations via a web interface and directly access the results.

With current telescopes, scientists can observe our Universe’s galaxies and galaxy clusters and their distribution along an invisible cosmic web. From the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Plants are networkers

19.06.2017 | Event News

Digital Survival Training for Executives

13.06.2017 | Event News

Global Learning Council Summit 2017

13.06.2017 | Event News

 
Latest News

Nanostructures taste the rainbow

29.06.2017 | Physics and Astronomy

New technique unveils 'matrix' inside tissues and tumors

29.06.2017 | Life Sciences

Cystic fibrosis alters the structure of mucus in airways

29.06.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>